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There is a significant public health concern
about the potential effects of occupational
exposure to toxic substances on reproductive
outcomes. Many toxicants with reported
reproductive and developmental effects are
still in regular commercial or therapeutic use
and thus present potential exposure to work-
ers. Examples of these include heavy metals
(lead, cadmium), organic solvents (glycol
ethers, toluene, vinyl chloride), pesticides and
herbicides (ethylene dibromide), and steri-
lants, anesthetic gases, and anticancer drugs
used in health care. Many other substances
are suspected of producing reproductive or
developmental toxicity.
Absence of sufﬁcient toxicologic and epi-
demiologic data lends a degree of uncertainty
to the estimated magnitude of risk that a spe-
ciﬁc toxicant presents. Against this backdrop,
government public health agencies are charged
with assuring the safety and health of wage
earners in the workplace. Unfortunately, the
majority of chemical toxicants regulated by
such agencies are not evaluated for reproduc-
tive or developmental toxicity. In a 1991 U.S.
General Accounting Office (U.S. GAO)
report prepared for the U.S. Senate, 30 chem-
icals considered to be reproductive and devel-
opmental toxicants were reviewed. The study
found that information on reproductive or
developmental toxicities was not available or
used in setting exposure limits for the major-
ity of these chemicals (U.S. GAO 1991).
The report concluded that public health 
“protection against reproductive and develop-
mental toxicity offered to the public by cur-
rent regulation is uncertain at best” (U.S.
GAO 1991).
It is estimated that 10–20% of recognized
pregnancies end in spontaneous abortion or
stillbirth (Hatasaka 1994) and as many are lost
before recognition of pregnancy (Wilcox et al.
1988; Zinaman et al. 1996). In addition,
10–15% of couples are unable to conceive
after 1 year of unprotected intercourse
(Chandra and Stephen 1998; Rudolph and
Forest 1990). Approximately 3% of all live
births have major malformations [Centers for
Disease Control and Prevention (CDC) 1995;
Holmes 1997; International Clearinghouse for
Birth Defects Monitoring Systems 1991;
National Center for Health Statistics 1998]. It
is estimated that 3% of these major malforma-
tions are strictly due to toxicant exposure
(Kimmel 1997; Oakley 1986), 28% can be
attributed to genetic causes, and approximately
23% are attributable to multifactorial causes,
which are complex interactions between genes
and environmental factors (Holmes 1997).
The cause is unknown in more than 40%
(Holmes 1997; Wilson 1973). What is
known, however, is that identifying the
causative agents, mechanisms by which they
act, and any potential target populations will
present the opportunity to intervene and better
protect the reproductive health of the public. 
Progress has been limited in identifying
hazards and quantifying their potencies and
in separating the contribution of these 
hazards from other etiologic factors. The pace
of laboratory studies to identify hazards and
to underpin the biologic plausibility of effects
in humans has not matched the pace at which
new chemicals are introduced into commerce.
In addition, the number of workers of repro-
ductive age potentially exposed to occupa-
tional chemical and physical agents has
grown. The percent of children born to work-
ing mothers has risen steadily from 31% in
1976 to 59% in 1998 (U.S. Census Bureau
2000a), and approximately 65% of employed
women and men are of reproductive age
(U.S. Census Bureau 2000b), thus providing
an increased probability of occupational
reproductive exposures.
Occupations with exposure to potential
reproductive toxicants include veterinary, den-
tal, and medical health care workers (Cordier
et al. 1991; Fedoruk 1996; Giacoia 1992;
Khattak et al. 1999; McDiarmid 1988;
McDonald 1988; Paul and Himmelstein
1988; Saurel-Cubizolles et al. 1985; Welch
1986); lab technicians (Giacoia 1992;
McDonald 1988; Paul and Himmelstein
1988); agricultural workers (McDonald 1988;
Ofﬁce of Technology Assessment Task Force
1985; Olshan et al. 1989; Vaughan et al.
1984); workers in construction (McDonald
1988); automobile mechanics and auto body
shop workers (Daniell and Vaughan 1988;
Giacoia 1992; Paul and Himmelstein 1988);
ﬁreﬁghters (Giacoia 1992); chemical industry
workers (Office of Technology Assessment
Task Force 1985); iron workers (Olshan et al.
1989); janitorial and cleaning persons
(McDonald 1988; Olshan et al. 1989); dry
cleaning and laundry persons (Giacoia 1992);
and persons working in different trades includ-
ing metal fitters, electronic technicians,
machinists and other metal tradesmen, and
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building and vehicles tradesmen (Ford et al.
1994). Several occupational exposures have
been reported in the literature as being 
associated with adverse reproductive outcomes,
including pesticides, solvents, and pharmaceu-
ticals (Giacoia 1992; Khattak et al. 1999;
Mattison and Thomford 1989; McDonald
1988; Ofﬁce of Technology Assessment Task
Force 1985; Paul and Himmelstein 1988;
Rachootin and Olsen 1983; Welch 1986).
However, studies that detail the relationship
between speciﬁc exposures and adverse repro-
ductive outcomes are much less common.
In 1993 Marcus et al. published an article
outlining a reproductive hazards research
agenda for the 1990s, and many of those
issues still apply today (Marcus et al. 1993). As
stated in that article, research on reproductive
outcomes is complicated because of the intri-
cate biology of reproduction, the multiple tar-
gets involved (male, female, offspring), the
uncertainties in extrapolating from model
species to humans, and the problems involved
in accurately characterizing exposure-related
outcomes in epidemiologic investigations. The
public health relevance of the study of repro-
ductive outcomes is not limited to couples
attempting to conceive. Because the endocrine
system is involved in many physiologic
processes, impaired reproduction may be a
marker for higher risk of reproductive cancers
(e.g., breast, ovarian, testicular), cardiovascular
disease, osteoporosis, and age-related cognitive
decline. Though reproductive research is com-
plicated and challenging, recent technologic
and methodologic advances have been made
that allow scientists to overcome some of these
obstacles.
In 1996 the National Institute for
Occupational Safety and Health (NIOSH)
and its partners implemented the National
Occupational Research Agenda (NORA) in
which approximately 500 organizations and
individuals outside NIOSH provided input
for the development of an agenda to improve
occupational safety and health. As one of the
21 research priority areas of NORA, members
of the Fertility and Pregnancy Abnormalities
Team have collaborated on this article to
develop research priorities. Thus, the objec-
tive of this article is to recommend future
directions in occupational reproductive health
research, with the purpose of reducing the
incidence of adverse reproductive health out-
comes. This can be accomplished with an
interdisciplinary research program that identi-
ﬁes reproductive hazards, their mechanisms of
toxicant action, and target populations.
Reproductive outcomes research.
Reproductive and developmental toxicity refers
to the continuum of adverse effects that may
befall an exposed child, parent, or pregnant
woman and her offspring exposed in utero.
Outcomes of reproductive performance
include infertility or subfertility and preg-
nancy loss, and structural malformations,
growth retardation, or functional deficits in
the developing organism. Exposure to toxi-
cants during gestation, postnatal development,
or later in life may affect gametogenesis, ovula-
tory function, sexual function, timing of
puberty and menopause, fertilization, implan-
tation, or any aspect of the developmental
process. Effects may be directly on the repro-
ductive system or embryo or indirectly on the
endocrine system that regulates reproduction.
Investigative studies of animal test species
can elucidate the mechanisms of action of a
toxicant. Studies for testing model species can
also include standard safety evaluations that
comprehensively assess the potential for a
chemical to affect the reproductive process.
Such studies evaluate the ultimate outcomes of
reproduction and development; that is, they
are apical in nature but provide little informa-
tion about the pathways by which adverse
effects occur. Numerous end points have been
added to these study protocols over the past
decade to make them more sensitive and to
include measurements that are more immedi-
ately interpretable in the context of fertility end
points measured in humans [Claudio et al.
1999; Clegg et al. 2001; U.S. Environmental
Protection Agency (U.S. EPA) 1998a]. These
include measurements of sperm production/
sperm number, sperm motility and morphol-
ogy, duration and regulation of estrous cycle,
and time of onset of puberty. Additional end
points have been added to enhance the ability
of these assays to determine the potential for
chemicals to affect estrogen, androgen, and
thyroid hormone function.
Identifying Hazards
A discrepancy exists between the number of
chemicals in commerce (approximately 84,000)
and the number that have been evaluated in
model species for reproductive toxicity potential
(4,000) (U.S. EPA 1998b). It is not feasible to
allocate additional resources to test the 80,000
or so untested chemicals through traditional
testing protocols, particularly given that about
2,000 new chemicals are introduced into com-
merce each year (U.S. EPA 1998b). Instead,
new, more rapid methods are needed to screen
large numbers of chemicals and to identify
those that are potential reproductive hazards. In
the near term, top priorities will be to develop
the most promising alternative models and to
test their ability to appropriately classify the
toxicity of sets of known toxicants and nontoxi-
cants. Successful alternative tests can then be
applied to the large list of chemicals of
unknown activity. The result would be a priori-
tized list for more comprehensive, traditional
toxicity testing in model species, accompanied
by ﬁeld studies for those compounds for which
human exposure is high or widespread.
High-throughput assays. High-throughput
assays evaluate the effect of a test substance on
a single biologic process using an automated
manner that allows thousands or tens of thou-
sands of compounds to be tested in a short
time at a reasonable cost. Robotics and genetic
engineering make it possible to produce large
quantities of receptors or genetically engi-
neered cells for use in these assays.
Knowledge about mechanisms of toxicity is
often central to the strategy of high-through-
put assays. For example, cells are being devel-
oped that are bioengineered to express human
hormone receptors for estrogens and andro-
gens. These cells can be used for high-through-
put chemical screening for steroid hormone
receptor affinity or the potential to act as
endocrine disruptors. Both isoforms of recom-
binant human estrogen receptor and human
androgen receptor are commercially available
for this purpose. The U.S. EPA plans to use
high-throughput assays for estrogens and
androgens to screen their initial list of 15,000
chemicals in the Toxic Substances Control Act
inventory and prioritize them for further evalu-
ation using more elaborate screens and tests
(U.S. EPA 1998b). Based on the same princi-
ples, other batteries of high-throughput assays
are available to screen for activity against vari-
ous receptors and cytochrome P-450 enzyme
isoforms. The availability and application of
these assays will undoubtedly expand as we
understand more about the relevance of each
protein in toxicologic processes.
Another approach for moderate or high-
throughput screening is to use genetically sen-
sitized embryos of simple organisms to screen
for effects on signal transduction. Signal trans-
duction is the process by which receptors send
information of ligand binding to the rest of the
cell and elicit a response. Compared with the
plethora of receptors that have been identiﬁed,
there are relatively few types of signal transduc-
tion; 17 pathways have been identiﬁed, and the
pace of discovery suggests that there are few left
to be revealed [National Research Council
(NRC) 1989]. Therefore, it is likely that toxi-
cants that affect different receptors may use the
same signal transduction pathway. If so, then
analysis of signal transduction pathways may
prove to be a tractable approach to high-
throughput screening that does not require set-
ting up thousands of receptor-based assays or
pinpointing an exact mechanism of toxicity.
Structure–activity prediction. Methods for
predicting activity from structure continue to
be developed and reﬁned. Computer programs
use available empirical information about the
toxicity of existing compounds and their
chemical characteristics to predict whether a
new compound will have similar toxicity.
These programs have not performed well in
the area of reproductive and developmental
toxicity, probably because reproductiveWorkshop Summary | Lawson et al.
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processes are complex and effects may be
elicited through multiple modes and mecha-
nisms. As science progresses and we learn more
about mechanisms of toxicity at the molecular
level, however, structure–activity computer
programs will become more exact and predic-
tive. The best examples are the programs that
are being developed and reﬁned for estrogen
receptor binding (Tong et al. 1997).
Integration of human studies and tests of
model species. Though 4,000 chemicals have
been tested in model species, few chemicals
have been adequately evaluated for reproduc-
tive effects in humans (Tables 1 and 2 contain
a partial list of known human developmental
and adult toxicants). Because the interpreta-
tion of studies of model species is often not
straightforward and because field studies are
labor and resource intensive, a systematic
approach is needed to select and prioritize
chemicals for epidemiologic studies.
Moorman et al. (2000) recently proposed a
process for selecting chemicals for human
field studies. In this process, information
gained from model species testing conducted
by the National Toxicology Program (NTP)
was reviewed for signiﬁcant adverse reproduc-
tive effects and potency of the toxicants. The
evaluative process then combined this infor-
mation with human exposure information
available in public databases to arrive at a list
of high-priority candidates for studies in
humans. Requests for Applications (RFAs)
have been used to encourage human studies
of some of these high-priority substances. In
2000, NIOSH, the U.S. EPA, the National
Institute of Environmental Health Sciences
(NIEHS), and the National Cancer Institute
cosponsored RFA “Endocrine Disruptors:
Epidemiologic Approaches” to encourage inves-
tigations of developmental effects of potential
endocrine disruptors. In 2001, NIOSH spon-
sored RFA “Occupational Exposure to Putative
Reproductive/Developmental Toxicants in
Humans” to stimulate studies of potential
reproductive/developmental effects of the
NTP-tested chemicals.
Latent effects. Functional deficits are
adverse developmental outcomes that do not
have obvious structural correlates. The detec-
tion of functional deﬁcits has long been rec-
ognized as a potential manifestation of
developmental toxicity, but functional deﬁcits
have not been examined routinely in hazard
assessments of model species. Heightened
awareness of (and concern for) these effects
have led to the modiﬁcation of model species
studies for testing toxicity to include assess-
ments of the latent effects on the developing
nervous, immune, and reproductive systems.
These studies will provide important informa-
tion on the range of potential outcomes that
may occur after developmental exposure to a
toxicant. Detection of such effects in humans
will be a challenge because the separation in
time of chemical exposure and observation of
an effect will hinder the identification of
causal factors. Birth defect registries cannot
account for such effects, and recall of early
exposures by adolescents or adults manifest-
ing effects is likely to be limited. It will be
important to conduct studies that record early
exposures and include follow-up of functional
competence in adulthood. Such studies have
not yet been conducted. However, the CDC,
the National Institutes of Health (NIH), and
the U.S. EPA are collaborating to propose a
large cohort study of infants followed into
adulthood to determine whether prenatal/
perinatal exposures are associated with long-
term effects (Children’s Health Act of 2000).
New biomarkers for humans and model
species. In 1977, men exposed to dibromo-
chloropropane (DBCP), a pesticide that is now
banned in the United States, were found to be
azoospermic and oligospermic (Whorton et al.
1977). Currently, a variety of biomarkers are
used to assess the potential adverse reproduc-
tive effects due to toxic chemical exposures.
Bioindicators of sperm production and quality
(semen volume, sperm concentration, sperm
motility, sperm morphology) are routinely
evaluated in ejaculated semen samples in men
and in suspensions of epididymal sperm from
test species (epididymal sperm reserves, sperm
motility, sperm morphology) (Moline et al.
2000; U.S. EPA 1998a). During the past
decade, computer-assisted methods developed
to improve and automate the evaluation of
sperm motion and morphology have been
added to the battery of routine sperm mea-
sures, and guidance for their use and interpre-
tation has been made available through a
number of workshops (Chapin et al. 1992; e.g.
ESHRE 1998; ILSI 1999; Schrader et al.
1991; Seed et al. 1996). Furthermore, baseline
data on the relationship between various semen
or epididymal sperm measures and fertility
have emerged from a number of large studies
designed to address this question (Bonde et al.
1998; Chapin et al. 1997; Zinaman et al.
2000). Thus, these measures are widely
accepted biomarkers of adverse reproductive
effects that are suitable for application in both
human and model species studies. Serum hor-
mone measures can also be determined in
humans and test species. Inhibin B has been
proposed as an indicator of testicular function
and a possible surrogate for sperm measures
(Anderson and Sharpe 2000).
The recognition that sperm functional
tests are also desirable has led to development
of various new tests that have only recently
been applied to toxicology. Biomarkers of the
genetic integrity of sperm are designed to
identify risks for paternally mediated develop-
mental effects. Sperm proteins are being tested
as biomarkers of fertility to detect specific
deficits in sperm function (as opposed to
decreased sperm output). Although details of
such tests are beyond the scope of this article,
Table 3 provides a list of new tests and refer-
ences regarding methodologic details and
examples of use. Further research is needed to
make these tests more practical and more cost
effective and to determine their ultimate util-
ity for hazard identiﬁcation and elucidation of
modes and mechanisms of toxicant action.
In females, biomarkers of effect include
the timing of onset of menarche, the pattern
of menstrual cyclicity, time to pregnancy, and
loss of fertility, as well as the measurement of
circulating steroid hormone (estrogen and
Table 1. Partial list of known human developmental
toxicants.a,b 
Physical
Ionizing radiation (atomic weapons, radioiodine, 
therapeutic X ray)
Hyperthermia
Biologic
Cytomegalovirus
Herpes simplex virus I and II
Parvovirus B-19
Rubella virus
Syphilis
Toxoplasmosis
Varicella virus
Venezuelan equine encephalitis virus
Chemical
Alcoholism
Aminopterin and methylaminopterin
Androgenic and antiandrogenic hormones
Busulfan 
Captopril
Chlorinated biphenyls
Cigarette smoking
Cocaine
Coumarin anticoagulants
Cyclophosphamide
Diethylstilbestrol
Diphenylhydantoin
Enalapril
Etretinate
Lead
Lithium
Mercury, organic
Methimazole
Misoprostol
Penicillamine
13-cis Retinoic acid
Tetracyclines
Thalidomide
Valproic acid
aDevelopmental toxicants are agents that cause structural
malformations, pregnancy loss, growth retardation, or
functional deﬁcits. bAdapted from Shepard 1998.
Table 2. Human adult reproductive toxicants.
Alcoholism
Antineoplastic agents
Ethylene glycol methyl ether
Carbon disulﬁde
Cigarette smoking
Dibromochloropropane
Ethylene glycol monoethyl ether
Hyperthermia
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progesterone) and pituitary hormone [follicle-
stimulating hormone (FSH), luteinizing hor-
mone, prolactin] levels. Biologic markers used
to assess effects of toxic chemicals during preg-
nancy include fetal viability, measurement of
circulating and/or urinary placental hormone
levels (estriol, progesterone, human chorionic
gonadotropin, human placental lactogen), and
the occurrence of developmental abnormali-
ties, especially in hormone-sensitive tissues
(NRC 1989). Because first-trimester preg-
nancy loss can be an imprecise tool, studies
incorporating cytogenic methods can offer the
advantage of documenting aneuploid and nor-
mal diploid karyotypes in exposed populations
(Marchetti et al. 1997; Silverman et al. 1985).
Biologic monitoring allows for evaluation
of hormone levels during menstrual cycles
(Kesner et al. 1999; Lipson and Ellison 1996;
Waller et al. 1998). An important considera-
tion in the overall validity of serum hormone
measurements has been pulsatility, or within-
subject temporal ﬂuctuations (Carandente et
al. 1989; McShane et al. 1996). Since the
1980s, investigators have been developing
indices of menstrual cycle function from hor-
mones or hormone metabolites excreted in
first-morning urine. Hormonal profiles
derived from blood samples have tradition-
ally been used to characterize clinically recog-
nized conditions such as polycystic ovarian
syndrome, anovulation, and luteal-phase
deﬁciency. Hormones and hormone metabo-
lite levels in urine generally parallel circulating
serum profiles of these hormones but would
not be expected to be identical. Urine hor-
mone levels are unlikely to reflect pulsatile
secretion patterns possibly found in serum,
and individual variation in steroid metabo-
lism and routes of excretion can also create
differences (Lasley et al. 1993). Nonetheless,
investigators have characterized multiple
indices of menstrual function, including
urine hormone levels and hormone ratios, in
groups of normal women. Several of these
markers are associated with conditions
including anovulation (Kassam et al. 1996),
reduced fertility, and the probability of con-
ception (Baird et al. 1999). Menstrual func-
tion studies of women working in the
semiconductor industry (Gold et al. 1995a),
with jet fuel (Reutman et al. 2002), or as
flight attendants (Whelan et al. 2002) have
been conducted or are in progress. Because
many of these markers vary with stage of life,
analyses should correct for age. As more
information becomes available on the use of
these markers in women exposed to potential
reproductive toxicants, they are likely to
become important descriptors of women’s
reproductive health in occupational studies.
Urinary hormone assays for additional
endocrine end points such as inhibin A and
B and leptin may also be useful.
Surveillance of human populations.
Improvement and expansion of public health
databases that can be tracked on a state- and
nationwide scale are crucial to identifying
causes of chronic disease and disability.
Historically, environmental causes of develop-
mental and reproductive defects were ﬁrst rec-
ognized by clinicians. For example, rubella
was shown to cause congenital cataracts, and
thalidomide was found to be teratogenic. In
both of these examples, and in others, the
association was discovered by an epidemic of
rare cases that occurred over a short time
frame. However, occupationally and environ-
mentally related diseases may not be as easily
identiﬁed if they produce a less severe, more
common outcome, making them more difﬁ-
cult to detect against a low but predictable
background of occurrence. Systematic collec-
tion of data makes identification of such 
relationships more feasible and cost effective.
Birth defect tracking in the United States
is handled on a state-by-state basis, and not
all states have a system in place (PEW 2000).
In 1997 the CDC established birth defects
centers in seven states: Arkansas, California,
Iowa, Massachusetts, New Jersey, New York,
and Texas. The CDC National Center for
Birth Defects and Developmental Disabilities
(NCBDDD) in Atlanta participates as the
eighth center. Each center is a collaboration
among state health departments, local hospi-
tals, universities, and the state chapter of the
March of Dimes Birth Defects Foundation. A
main activity of the centers is to participate in
the National Birth Defects Prevention Study,
a case–control study of major structural birth
defects (Yoon et al. 2001).
Traditionally, data available in the few
existing birth defect surveillance systems rarely
included information on potential occupational
or environmental exposures. There are two
issues regarding existing birth defect surveil-
lance with respect to occupation: a) How can
existing systems be better used for epidemio-
logic research, including research on occupa-
tional exposures? b) Can parental occupation
and industry data be reliably incorporated into
existing surveillance systems?
Establishment of a national cancer death
registry has been a useful tool in testing
hypotheses regarding the relationship between
environmental exposures and cancer occur-
rence. This registry allows researchers to evalu-
ate the distribution of disease by age, race, sex,
geography, and other related factors.
Incorporation of occupational exposure infor-
mation into existing surveillance systems
requires an investment of additional resources.
To correctly address the issue of linking the
timing of exposure to a critical susceptibility
period, questionnaires should include infor-
mation on employment during pregnancy.
Currently, NIOSH is working with the CDC
NCBDDD to develop an approach to expo-
sure assessment of parental occupational data
that were collected as part of the National
Birth Defects Prevention Study. Analyses will
not be able to account for congenital anomalies
in fetuses that were miscarried or electively ter-
minated and therefore not represented in birth
registries. However, registries of birth defects
and of other adverse developmental and
reproductive outcomes, though difficult and
expensive to do, could generate new etiologic
hypotheses and improve the feasibility of the
research.
Estimating occupational exposure.
Establishing that a significant number of
workers or members of the general population
are or will be exposed to a potential reproduc-
tive toxicant is central to priority setting.
NIOSH’s National Occupational Hazard
Survey and National Occupational Exposure
Survey conducted in 1972–1974 and
1981–1983, respectively, has been used exten-
sively to identify substances of common expo-
sure (NIOSH 1978, 1988). These surveys are
Table 3. Emerging biomarkers of male reproductive effects.
Selected references 
Target Bioassay Function assessed and reviews
Sperm DNA SCSA Chromatin damage Evenson 1999
TUNEL DNA damage Perreault et al. 2000
COMET
CMA3 staining
DNA adducts
Sperm chromosomes FISH Aneuploidy, breakage, Robbins et al. 1999
translocation Hassold 1998
Sloter et al. 2000
Fertilizing ability SP-22 protein Welch et al. 1998
Sperm antigens Diekman and Herr 1997
Ubiquitin Sutovsky et al. 2001
Sperm maturity Cytoplasmic droplets Huszar et al. 2000
Heat shock protein A2
Sperm count surrogate Inhibin B Endocrine feedback Anderson and Sharpe 2000
of spermatogenesis
Abbreviations: CMA3 staining, chromomycin A3 staining; COMET, single-cell gel electrophoresis assay; FISH, 
fluorescence in situ hybridization; SCSA, sperm chromatin structure assay; TUNEL, terminal deoxynucleotidyl trans-
ferase-mediated dUTP-biotin end-labeling.Workshop Summary | Lawson et al.
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the only comprehensive assessments of gen-
eral industry where the number of workers
potentially exposed to chemical agents has
been estimated. However, these databases are
outdated and of limited use because they indi-
cate only potential exposure. NIOSH is cur-
rently planning a new hazard surveillance
activity that will target industry sectors on a
rolling basis, beginning with the health care
sector. Public health researchers will continue
to require updated exposure surveys to keep
up with the changing workplace exposures
and monitor new exposures that may be
potential reproductive toxicants. New tech-
nologies such as geographic information sys-
tems (GIS) allow mapping of industries and
specific chemical exposures. Use of GIS to
identify geographic areas with high volume of
use of suspect chemicals might be an effective
method of identifying populations with greater
potential occupational and environmental
exposures.
In the absence of birth defects surveillance
systems, the coding of parent’s occupation and
industry (O/I) could be collected on vital sta-
tistics records or national surveys of reproduc-
tive health. For example, the National Survey
of Family Growth and the National Maternal
and Infant Health Survey have limited O/I
information. Although occupation and indus-
try are part of the National Health and
Nutrition Examination Survey (NHANES),
this information cannot be linked with each
pregnancy time period. Additional survey data
could be added to NHANES and its updates,
providing an opportunity for epidemiologic
studies, but such additions are costly and com-
pete with other priorities. Through the
NORA program, NIOSH has made efforts to
leverage intramural resources to develop col-
laborative research in NORA areas. As an
example, collaboration between NIOSH and
Harvard researchers is under way to obtain
exposure and reproductive information in the
Nurses’ Health Study, a large cohort study of
female nurses, by adding a supplemental ques-
tionnaire for a subset of the cohort.
Parental occupation is recorded on birth
and fetal death certificates in some states.
NIOSH has supported efforts to include O/I
on birth certiﬁcates in about 20 states and to
develop software to reduce verbatim O/I
information to Bureau of Census codes. The
NIOSH Standardized Occupation/Industry
Coding System software (SOIC) can be used
for birth or death certiﬁcates and reduces ver-
batim O/I input to 1990 Bureau of Census
codes with 86–88% success. Cancer registries
are an existing data source for childhood can-
cer incidence. Approximately 45 states are
funded to maintain cancer registries, but
most do not collect O/I of parents. A few
states have begun to add this information.
Improvement in existing surveillance by
wider use of O/I data might increase our
ability to identify new exposures for study.
Biomonitoring is a valuable tool for 
estimating occupational exposure. Male and
female reproductive information and biomark-
ers (e.g., age at menopause, FSH) have been
incorporated into some portions of the
NHANES survey. The National Report
on Human Exposure to Environmental
Chemicals is a new and ongoing assessment of
the U.S. population’s exposure to environ-
mental chemicals based on data from CDC’s
NHANES 99 (CDC 2001). The ﬁrst edition
of the report presents levels of 27 environmen-
tal chemicals, including metals (e.g., lead,
mercury, uranium), cotinine (a marker of
tobacco smoke exposure), organophosphate
pesticide metabolites, and phthalate metabo-
lites. Scientists at the CDC and NTP reported
results of analysis of human urine for the
metabolites of phthalate plasticizers (Blount et
al. 2000). This is a signiﬁcant step forward in
assessing the potential human toxicity of a
class of chemicals known to be reproductive
and developmental toxicants in rodents.
Improved methods for analysis of exposure,
especially of age and time effects, are likely to
impact the characterization of occupational
exposure in these studies (Richardson and
Wing 1998).
Current research approaches usually con-
sider the action of single, unique toxicants on
outcomes of interest, creating yet another
challenge to drafting a reproductive hazards
agenda. The more common human exposure
scenario is to mixtures of toxicants at low con-
centrations, episodically and over the long
term. Attention to cumulative exposure over
years of a working lifetime and total aggregate
exposure to toxicants from multiple exposure
sources, as well as classical considerations of
exposure routes, must also be addressed.
Methodologic approaches must enlarge and
mature to consider the effects and modulation
of effects mediated by both exposure to mix-
tures of toxicants and the complexities
of exposure mode at low dose and over
prolonged duration.
Epidemiologic studies of occupational
exposures. Not all health effects are easily iden-
tiﬁed through surveillance systems such as reg-
istries. Timing and dose of exposure affect the
outcome. Adverse pregnancy outcomes such as
spontaneous abortion are not routinely
reported, and many cognitive defects are iden-
tified several years after birth. Reproductive
effects such as altered semen quality in men
and changes in hormone balance in both men
and women require laboratory analyses and
would warrant a more extensive surveillance
system to identify changes in distribution over
person, place, or time. Because of limited reg-
istry data, researchers have used a combination
of company work histories and validated
reproductive questionnaire information to
study reproductive outcomes, including fetal
loss, birth defects, reduced fertility (several
indices including time to pregnancy), sex
ratio, birth weight, and gestational age.
Menstrual function biomonitoring studies
can complement pregnancy outcome studies
by measuring sensitive hormonal markers of
female infertility and subfertility in smaller
groups of female workers. As described earlier,
methods developed in clinical settings have
now been modified for workplace biomoni-
toring studies to enable women to collect and
store series of daily urine and/or saliva sam-
ples, often in conjunction with diary informa-
tion. These studies should lead to better
understanding of the responses to exposure.
Male reproductive studies are modest in
cost, require relatively few participants, and
can indicate the potential dysfunctional
impact of a reproductive toxicant with minor
changes in the male reproductive profile.
Workplace studies of over 50 measures of
semen quality, male reproductive hormones,
and survey measures of potency and libido
have described longitudinal normal semen
quality values for working men (Schrader et al.
1998) and identified reproductive hazards
(Grajewski et al. 1996, 2000; Ratcliffe et al.
1989; Schrader et al. 1988; Whelan et al.
1996). Though difficult to do, if national
cohort studies included semen analyses along
with other biologic samples, it would provide
important population-based data with which
to compare exposed workers.
Opportunities in Mechanistic
Research
Understanding mechanisms of action of toxi-
cants is important for a number of reasons,
including a) supporting the biologic plausi-
bility of an observed association between
chemical exposure and adverse outcome;
b) uncovering common pathways of actions of
different agents; c) extrapolating across species
for risk assessment; d) improving the pre-
dictability of human morbidity from responses
of model species; and e) predicting responses
to mixed exposures.
Mechanistic studies are not new in toxi-
cology; however, new tools in genomics,
proteomics, and bioinformatics present
unprecedented opportunities to advance our
understanding of toxicant action at a molecular
level. Genomic information and the ability to
screen most or all of the genome of an increas-
ing number of organisms for changes in gene
expression are revolutionizing the way in which
biologic effects data are gathered. It is now pos-
sible to determine the effects of a toxicant
exposure on gene expression of most of the
genome of mice and rats. This will allow us to
generate testable hypotheses about the 
mechanism of action of toxicants. It will alsoWorkshop Summary | Occupational reproductive research agenda
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open up the possibility of identifying markers
of exposure or effect specific to a particular
insult that can be used in field studies. Such
markers will aid in determining whether statis-
tical associations between a given exposure and
effect have biologic plausibility. For example, a
recent study identiﬁed selective genes that were
expressed in vitro in decidualized human
endometrial stromal cells in response to proges-
terone or cyclic adenosine monophosphate
(Popovici et al. 2000).
As with any new technology, a number of
problems will need to be overcome for the
promise of genomics to be realized. The ﬁrst
will be to manage the large volume of infor-
mation produced by gene expression experi-
ments. Gene chips may contain thousands or
tens of thousands of sequences. Experience
shows that any perturbation in a biologic sys-
tem leads to numerous changes in gene
expression. An entire ﬁeld of bioinformatics is
being developed to help collect, organize, and
manage the data to identify changes related
temporally, by dose, or by metabolic pathway.
The second challenge will be to separate those
changes in gene expression pivotal to the toxic
response from those that are more generalized
responses to any stimulus. The third chal-
lenge will be to quantitatively relate changes
in expression of critical genes with toxicity,
which is manifested at a more complex level
of biologic organization (i.e., the cell, organ,
or organism). Real comfort in this genomic
approach will come only with experience and
the development of a large database. Toward
this end, NIEHS recently announced the
establishment of the National Center for
Toxicogenomics (NCT; Anonymous 2001).
Gene–Environment Interactions
Reproductive toxicants can affect human
populations over the total life span, including
the in utero and perinatal periods, childhood,
puberty, and adulthood. Thus, extending
research efforts to address stage-speciﬁc sensi-
tivity is recommended. Another emerging
approach allows the identiﬁcation of popula-
tions at potentially increased risk from toxi-
cant exposure by characterizing genetic
polymorphisms of metabolizing enzymes in
exposed cohorts. Such methods may identify
vulnerable subpopulations on the basis of
inherent (genetic) differences in their ability
to metabolize a toxicant.
Identifying genes that increase sensitivity
to reproductive toxicants. Genetic factors that
elevate risk for disease can be grouped into
two categories: those for which having a par-
ticular allele conveys a high risk for the disease
regardless of other (e.g., environmental) inﬂu-
ences, and those associated with only small
increases in risk of the disease. The latter,
termed susceptibility genes, are being 
identiﬁed at an increasing rate. The interaction
of these alleles with environmental agents or
other susceptibility alleles ultimately deter-
mines whether the disease will be manifested.
Much work has been done to understand the
role of these genes in cancer etiology [see
Caporaso and Rothman (1999) for a review],
and some susceptibility genes for reproductive
toxicity are now being identiﬁed. Identifying
these genes will be critical in understanding
the role that the environment plays in the
25% of birth defects described as being multi-
factorial in nature, as well as in many or most
of those of unknown etiology. Other repro-
ductive gene–environment interactions are
being reported, most recently for an associa-
tion between low-level occupational benzene
exposure and shortened gestational length
modiﬁed by the presence of two susceptibility
genes (Wang et al. 2000). In another study a
high rate of oral clefts (cleft lip with or with-
out cleft palate) was reported for offspring of
mothers who were heavy cigarette smokers
during pregnancy but only if the baby carried
a variant allele of the transforming growth fac-
tor-alpha gene (Hwang et al. 1995; Shaw et al.
1996). Cigarette smoking combined with the
genetic variant increased the risk more than
10-fold compared with the reference group.
Rare alleles of the Msx1 gene, a homeobox
gene involved in early embryonic pattern for-
mation, are associated with a slightly increased
risk for limb reduction defects. Cigarette
smoking during pregnancy doubles the risk of
limb defects in infants with the rare alleles;
cigarette smoking alone had no effect (Hwang
et al. 1998). These examples show the power
of genetic analysis in combination with tradi-
tional case-control studies in identifying risk
factors for abnormal development.
As we learn more about the human
genome and about individual polymorphisms
that alter susceptibility, it will be possible to
design molecular epidemiology studies more
routinely to include analysis of putative suscep-
tibility genes. On 1 October 1990, the Human
Genome Project (HGP) was initiated through
partnership and funding by the NIH and the
U.S. Department of Energy. At least 20 inter-
national research centers (referred to as the
International Human Genome Consortium)
collaborated on this public project. The initial
goals of this project were to map the entire
human genome, develop the technology to
accomplish the sequencing of DNA, and
characterize the genomes of model laboratory
organisms such as yeast, bacteria, worms, ﬂies,
and mice, all within a time frame of 15 years.
It was the expressed goal of the HGP that all
sequence data generated by this effort be
freely available and remain in the public
domain. Because of steady progress in achiev-
ing the initial goals of this project, the aims
were expanded to include a) complete the 
sequencing of the entire human genome by
2003, b) further improve the current sequenc-
ing technology, c) identify and map single
nucleotide polymorphisms (SNPs) distributed
throughout the genome, and d) elucidate the
function of each gene (by examining the
expression pattern of each gene under various
experimental conditions), as well as several
additional goals (Collins et al. 1998). In
1997 NIEHS presented a plan called the
Environmental Genome Project (EGP) that
would characterize the variations (SNPs) in
selected human genes and relate these differ-
ences to variations in susceptibility to environ-
mental chemicals (Kaiser 1997). Although
there is potential for overlap in the identiﬁca-
tion of SNPs between the HGP and EGP, cur-
rent plans of the EGP are to focus on an
estimated 200 genes coding for proteins/
enzymes involved in drug metabolism, oxida-
tive stress responses, cell cycle components,
and DNA repair mechanisms (Guengerich
1998). In 1998 a biotechnology company,
Celera Genomics (the commercial project),
announced its plans to sequence the human
genome. In February 2001, a draft sequence of
the human genome was published by the
International Human Genome Consortium
(International Human Genome Consortium
2001) and Celera Genomics (Venter et al.
2001). Although this draft sequence is incom-
plete, it lays the foundation for understanding
the genetic basis of disease susceptibility and
the individual variability in sensitivity/respon-
siveness to drugs. Of course, in addition to
genomic data, information on epigenetic
changes that inﬂuence gene expression may be
important in understanding susceptibility and
adverse response to environmental contami-
nants (Holliday 1998).
Potential information from genetics to
advance epidemiologic studies. One of the
goals of the HGP is to identify and map SNPs
and to determine how these variations confer
susceptibility or resistance to human diseases,
whereas the more limited goal of the EGP is to
identify SNPs of selected genes that may confer
increased sensitivity to environmental toxins.
After the DNA sequence variations are identi-
ﬁed, they must be correlated with functional
changes in the expression and/or activity of
protein/enzymes encoded by the genes at the
tissue/cellular level. If epidemiologic studies
could identify genetic–toxicant interactions by
comparing the prevalence of a particular
genetic marker (polymorphism) or a group of
markers in affected and unaffected populations
(Collins et al. 1997), this information could be
used to target environmental, behavioral, or
medical interventions (Khoury 1997).
Ultimately, validation of genetic testing to link
a particular genotype with exposure to a
speciﬁc chemical to the increased prevalence of
a particular reproductive disorder would
require epidemiologic confirmation (KhouryWorkshop Summary | Lawson et al.
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and Dorman 1998). Although genetic testing
will enhance the sensitivity of epidemiologic
studies, this information must be used judi-
ciously to protect individuals from discrimina-
tion, as there are ethical issues regarding
identiﬁcation of vulnerable populations in the
workplace. Controlling exposures in the work-
place remains the best option for preventing
occupationally related disease for all workers.
Communication
An essential component of future reproductive
studies will be improved communication.
Because of the complex mechanisms involved
in reproductive research, collaboration across
scientific disciplines must be conducted. In
addition, notification of research results and
recommendations must be communicated to
workers and the affected public in a manner
that is timely, accessible, and easily understood.
Partnerships across disciplines. In cur-
rent and future studies, the measurement
and characterization of adverse health effects
due to reproductive toxicants will depend
more on the understanding and collabora-
tion of partners in multiple disciplines.
Epidemiologists, toxicologists, molecular biol-
ogists, and statisticians have found it essential
and ultimately very valuable to collaborate to
take advantage of new methodologies. Two
key partners, epidemiologists and toxicolo-
gists, have begun to work together, although
the nature of each of these disciplines has led
to operational discomfort along the way
(Swan and Lasley 1991).
The motivation to form partnerships
across disciplines also derives from the limita-
tions of each of the individual disciplines and
the potential to overcome these limitations.
For the epidemiologist, biologic monitoring
can increase study power, increase the preci-
sion of exposure assessment to minimize mis-
classiﬁcation, and decrease selection bias. This
becomes increasingly important in studying
lower levels of exposure, for which the nature
of the outcome response will depend on the
mechanisms of toxicologic effects (Guidotti
1995). For the toxicologist, well-designed
observational human studies offer the general-
ization to humans often lacking in toxicologic
study design (Pershagen 1999).
One example of beneficial multidiscipli-
nary collaboration has been the development
of field methods and the analysis of urinary
reproductive hormones and hormone
metabolites (Swan and Lasley 1991). Study
participant collection of small amounts of
daily urine for one or more menstrual cycles
has been successful in several environmental
studies and in occupational groups including
semiconductor workers (Gold et al. 1995b)
and actively traveling flight attendants
(Whelan et al. 2002). Modification of the 
hormone assays for ﬁeld use has resulted in an
effective biomonitoring metric for ovulatory
function, early pregnancy loss, premature
menopause, and other important reproductive
outcomes. Moving these tests successfully into
the ﬁeld requires that laboratory speciﬁcations
for stability, preservation, and sample size be
met; that the laboratories meet the analysis
demands of repeated measures from the rela-
tively large numbers of women in these stud-
ies; and that the epidemiologists and
laboratory scientists reach consensus on study
design elements, including laboratory-based
deﬁnitions of outcomes and units of observa-
tion. This last requirement often results in the
unanticipated benefit that both disciplines
begin to think about study end points and
outcomes in a new way (e.g., a laboratory-
based, epidemiologically meaningful defini-
tion of “pregnancy” or “early menopause”).
Several formal collaborative efforts have
been organized. The Center for the Evaluation
of Risks to Human Reproduction (CERHR)
was established in 1998 by the NTP and
NIEHS. The center provides scientiﬁc assess-
ments of reproductive health risks associated
with human chemical exposures. These assess-
ments are being made available to the public
through the CERHR website (CERHR
2002). The NCT, recently established by
NIEHS, is another example of a collaborative
effort aimed at advancing scientiﬁc knowledge
of biologic responses for public health
use. The NORA Fertility and Pregnancy
Abnormalities Team is working with the
CERHR and others to develop reproductive
research priorities and to increase communica-
tion between professionals and the public
(NIOSH 2003).
These examples of collaboration should
encourage researchers to work together more
in the future. Reporting results at shared sci-
entiﬁc meetings would also inform our collec-
tive understanding, suggest avenues of
collaboration, and build efﬁciently on existing
knowledge while avoiding redundancy.
Within the government research community,
a mechanism is needed to routinely share
research agendas and possibly chart collabora-
tions. Presently, this activity is accomplished
passively or only through personal communi-
cation. There is a role for larger public–private
partnerships in both achieving research goals
and disseminating results as well. The NIOSH
NORA program is one example of such
a partnership.
Communicating research findings.
Advances in reproductive toxicology and epi-
demiology lose their public health relevance if
the enhanced ﬁndings these methods permit
do not reach policy makers, employers, and
affected persons and help them to make
informed decisions. For example, we note
that both government agency and industry-
sponsored research results may not routinely
be published in the peer-reviewed literature.
Often, reasons for failing to do this are not as
much due to trade secrets as to time and
resource constraints of the investigators.
Developing and providing effective com-
munication is a major challenge within the
public health and occupational health com-
munities. Effective health communication is a
component of intervention effectiveness,
another NORA priority area currently framing
new NIOSH intramural research projects.
Material Safety Data Sheets (MSDSs) are a
primary means of communicating hazards to
workers. Paul and Kurtz (1994) surveyed
Massachusetts MSDSs for products contain-
ing two known reproductive toxicants, lead
and glycol ethers, and found that over 60%
did not mention possible reproductive health
effects. Reproductive risk information for
workers in clinical settings or participating in
health studies has often been absent, poorly
written, or unclear. As a result, workers’
understanding of reproductive hazards is deﬁ-
cient. Although maternal recall of reproduc-
tive history has been found generally to be of
good quality (Selevan 1980), a recent survey
indicated relatively poor maternal recall of
potential workplace reproductive hazards
(Bauer et al. 1999).
The message that reproductive health
includes both men and women, and that it can
be affected by their workplace exposures, needs
to reach the workers and their employers. Paul
and Kurtz (1994) found that where reproduc-
tive hazards were mentioned in MSDSs, they
were 18 times more likely to address develop-
mental effects than male reproductive risks. Of
50 patients surveyed who visited an occupa-
tional reproductive consulting service, 39 were
women with clinically recognized pregnancies.
Only 1 man and 10 women contemplating
pregnancy were seeking counseling (Frazier
and Jones 2000). Generally, NORA Team
researchers have found that workers are very
interested in reproductive health, and that
nontechnical summaries of study ﬁndings, as
well as personal results, are well received and
understood by these groups.
Summary and
Recommendations
A primary goal of reproductive research is to
reduce the high percentages of adverse out-
comes such as infertility, pregnancy loss, and
congenital malformations. Although certain
limitations exist that are unique to reproduc-
tive research, many advances in technology
and methodologies have been recently devel-
oped that will aid researchers in their efforts
to a) understand mechanisms by which
toxicants exert their effects, b) identify popu-
lations at risk, and c) evaluate reproductive
and developmental hazards to improve public
health. These tools and resources include Workshop Summary | Occupational reproductive research agenda
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• High-throughput assays
• Structure–activity prediction
• Biomarkers of exposure and effect
• Exposure databases
• GIS
• NIOSH SOIC System
• Genomics
• Proteomics
• Bioinformatics
• HGP and EGP
With the use of these new tools comes a
responsibility among researchers to improve
existing efforts and reach out into new areas
of research. The authors make the following
recommendations:
• Prioritization of research needs
– New toxicology studies should be priori-
tized based on chemical structure and
volume of use.
– Field studies should be prioritized based
on toxicologic studies combined with
human exposure information.
• Potential surveillance activities
– Evaluate occupational exposure data avail-
able from existing surveillance systems.
– Expand additional birth defects surveil-
lance systems to include a greater popu-
lation in the United States.
– Add reproductive biologic markers and
semen characteristics to national surveys.
• New studies should assess gene–environ-
ment interactions and effects of mixtures of
chemicals whenever appropriate.
• Research results should be communicated
to the policy makers and affected public
through widely accessible, nontechnical
reports and summaries.
• Improved communication among research
disciplines and should be encouraged
through
– Interdisciplinary research protocols
– Organized collaborative teams
– Shared scientiﬁc meetings/workshops
– Dissemination of results to wider
audiences.
By bridging interdisciplinary gaps, the
scientific community can work together to
improve health and reduce adverse health
outcomes.
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